Global, regional, and national prevalence and disability-adjusted life-years for endometriosis in 204 countries and territories, 1990– 2019: findings from a global burden of disease study

In: Research Square · 2024 · doi:10.21203/rs.3.rs-3857347/v1 · W4390947985
preprint OA: green CC0 ⤵ 2 in-corpus citations
📄 Open PDF View on OpenAlex View at publisher
AI-generated summary by claude@2026-06+body, 2026-06-07

This study analyzed global, regional, and national endometriosis prevalence and disability-adjusted life-years from 1990-2019, finding a decreasing trend with increasing sociodemographic index and a peak prevalence between ages 25-29.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-07

This Global Burden of Disease (GBD) study used GBD 2019 data to estimate endometriosis prevalence (including numbers and age-standardized prevalence rates) and disability-adjusted life-years (DALYs) from 1990–2019 across 204 countries and territories, and assessed trends using Bayesian meta-regression (disMOD-MR 2.1) and age–period–cohort analyses. Globally, age-standardized prevalence rates for endometriosis declined by 20.47% from 1990 to 2019, with DALYs rates decreasing from 71.08 to 56.61 per 100,000, and prevalence peaking between ages 25–29. Declines in age-standardized prevalence were seen across all SDI quintiles and most regions, with the largest reductions reported in Central Latin America, South Asia, and high-income North America, while some European regions showed smaller decreases. The paper is a preprint and therefore not peer reviewed, which is its main stated limitation, and it relates to endometriosis by providing global, regional, and national estimates of prevalence and DALYs over time using GBD 2019.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (38)

Cited by (2)

Source provenance

europepmc
last seen: 2026-06-15T06:13:43.845377+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK